Olmesartan/Hydrochlorothiazide STADA Arzneimittel AG 40 mg/25 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan/hydrochlorothiazide stada arzneimittel ag 40 mg/25 mg film-coated tablets

stada arzneimittel ag - olmesartan medoxomil; hydrochlorothiazide - film-coated tablet - 40 mg/25 milligram(s) - angiotensin ii antagonists and diuretics; olmesartan medoxomil and diuretics

OLMESARTAN/ AMLODIPINE HCT Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan/ amlodipine hct

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 13.888 mg/mg (equivalent: amlodipine, qty mg); hydrochlorothiazide, quantity: 25 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - olmesartan/ amlodipine hct - myl is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

OLMESARTAN/ AMLODIPINE HCT Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan/ amlodipine hct

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg) - tablet - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - olmesartan/ amlodipine hct - myl is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

OLMESARTAN/ AMLODIPINE HCT Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan/ amlodipine hct

organon pharma pty ltd - olmesartan medoxomil, quantity: 20 mg; amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg); hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; croscarmellose sodium; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - olmesartan/ amlodipine hct - myl is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

OLMESARTAN HCT Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan hct

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

OLMESARTAN SANDOZ olmesartan medoxomil 10 mg film coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan sandoz olmesartan medoxomil 10 mg film coated tablets blister pack

sandoz pty ltd - olmesartan medoxomil, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; microcrystalline cellulose; hyprolose; purified water; hypromellose; titanium dioxide; iron oxide yellow; macrogol 4000 - olmesartan sandoz is indicated for the treatment of hypertension.

OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE ACCORD Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/hydrochlorothiazide accord

accord healthcare limited - olmesartan medoxomil ; hydrochlorothiazide ep - film coated tablet - 20/25 milligram - olmesartan medoxomil and diuretics

OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE ACCORD Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/hydrochlorothiazide accord

accord healthcare limited - olmesartan medoxomil ; hydrochlorothiazide ep - film coated tablet - 40/12.5 milligram - olmesartan medoxomil and diuretics

OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE ACCORD Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/hydrochlorothiazide accord

accord healthcare limited - olmesartan medoxomil ; hydrochlorothiazide ep - film coated tablet - 40/25 milligram - olmesartan medoxomil and diuretics

Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Clonmel 20 mg/5 mg/12.5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine/hydrochlorothiazide clonmel 20 mg/5 mg/12.5 mg film-coated tablets

clonmel healthcare ltd - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 20 mg/5 mg/12.5 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide